subscribeSubscribe
price-trendAsk Us
NICE does not recommend elosulfase alfa for Morquio A syndrome

NICE does not recommend elosulfase alfa for Morquio A syndrome
Anna Begley EUROPEANPHARMACEUTICALREVIEW
16 Nov 2021
Share Share
BioMarin`s Vimizim (elosulfase alfa) Receives Supplemental Approval in US

BioMarin`s Vimizim (elosulfase alfa) Receives Supplemental Approval in US
FDA
04 Dec 2019
Share Share
BioMarin Announces Approval of Vimizim

BioMarin Announces Approval of Vimizim
PR NEWSWIRE
04 Jun 2019
Share Share
BioMarin investing $43M in fill-finish line at plant in Ireland

BioMarin investing $43M in fill-finish line at plant in Ireland
Eric Palmer FIERCE PHARMA
04 Sep 2018
Share Share